Poehling Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.54M | Sell |
|
|||||
|
2025
Q2 | $2.65M | Sell |
|
|||||
|
2025
Q1 | $3.49M | Buy |
|
|||||
|
2024
Q4 | $3.23M | Sell |
|
|||||
|
2024
Q3 | $2.96M | Buy |
|
|||||
|
2024
Q2 | $2.31M | Sell |
|
|||||
|
2024
Q1 | $5.89M | Buy |
|
|||||
|
2023
Q4 | $5.56M | Sell |
|
|||||
|
2023
Q3 | $6.03M | Buy |
|
|||||
|
2023
Q2 | $5.72M | Buy |
|
|||||
|
2023
Q1 | $6.11M | Buy |
|
|||||
|
2022
Q4 | $6.04M | Sell |
|
|||||
|
2022
Q3 | $4.54M | Buy |
|
|||||
|
2022
Q2 | $346K | Sell |
|
|||||
|
2022
Q1 | $2.65M | Buy |
|
|||||
|
2021
Q4 | $2.24M | Buy |
|
|||||
|
2021
Q3 | $1.73M | Buy |
|
|||||
|
2021
Q2 | $1.9M | Buy |
|
|||||
|
2021
Q1 | $1.72M | Buy |
|
|||||
|
2020
Q4 | $1.04M | Buy |
|
|||||
|
2020
Q3 | $750K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $6K | Sell |
|
|||||
|
2018
Q1 | $34K | Buy |
|
|||||
|
2017
Q4 | $27K | Buy |
|